287 related articles for article (PubMed ID: 36943800)
1. The Underappreciated Role of Secretory IgA in IBD.
Bamias G; Kitsou K; Rivera-Nieves J
Inflamm Bowel Dis; 2023 Aug; 29(8):1327-1341. PubMed ID: 36943800
[TBL] [Abstract][Full Text] [Related]
2. Antibody secreting cells are critically dependent on integrin α4β7/MAdCAM-1 for intestinal recruitment and control of the microbiota during chronic colitis.
Tyler CJ; Guzman M; Lundborg LR; Yeasmin S; Zgajnar N; Jedlicka P; Bamias G; Rivera-Nieves J
Mucosal Immunol; 2022 Jan; 15(1):109-119. PubMed ID: 34433904
[TBL] [Abstract][Full Text] [Related]
3. An integrin αEβ7-dependent mechanism of IgA transcytosis requires direct plasma cell contact with intestinal epithelium.
Guzman M; Lundborg LR; Yeasmin S; Tyler CJ; Zgajnar NR; Taupin V; Dobaczewska K; Mikulski Z; Bamias G; Rivera-Nieves J
Mucosal Immunol; 2021 Nov; 14(6):1347-1357. PubMed ID: 34417548
[TBL] [Abstract][Full Text] [Related]
4. A mutation that blocks integrin α
Zhang H; Zheng Y; Pan Y; Lin C; Wang S; Yan Z; Lu L; Ge G; Li J; Zeng YA; Chen J
BMC Biol; 2020 Jun; 18(1):64. PubMed ID: 32522281
[TBL] [Abstract][Full Text] [Related]
5. Regulation and Role of αE Integrin and Gut Homing Integrins in Migration and Retention of Intestinal Lymphocytes during Inflammatory Bowel Disease.
Keir ME; Fuh F; Ichikawa R; Acres M; Hackney JA; Hulme G; Carey CD; Palmer J; Jones CJ; Long AK; Jiang J; Klabunde S; Mansfield JC; Looney CM; Faubion WA; Filby A; Kirby JA; McBride J; Lamb CA
J Immunol; 2021 Nov; 207(9):2245-2254. PubMed ID: 34561227
[TBL] [Abstract][Full Text] [Related]
6. Blockade of αEβ7 integrin suppresses accumulation of CD8
Zundler S; Schillinger D; Fischer A; Atreya R; López-Posadas R; Watson A; Neufert C; Atreya I; Neurath MF
Gut; 2017 Nov; 66(11):1936-1948. PubMed ID: 27543429
[TBL] [Abstract][Full Text] [Related]
7. Anti-Integrins for the Treatment of Inflammatory Bowel Disease: Current Evidence and Perspectives.
Gubatan J; Keyashian K; Rubin SJS; Wang J; Buckman CA; Sinha S
Clin Exp Gastroenterol; 2021; 14():333-342. PubMed ID: 34466013
[TBL] [Abstract][Full Text] [Related]
8. Anti-β7 integrin treatment impedes the recruitment on non-classical monocytes to the gut and delays macrophage-mediated intestinal wound healing.
Sommer K; Heidbreder K; Kreiss L; Dedden M; Paap EM; Wiendl M; Becker E; Atreya R; Müller TM; Atreya I; Waldner M; Schürmann S; Friedrich O; Neurath MF; Zundler S
Clin Transl Med; 2023 Apr; 13(4):e1233. PubMed ID: 37029786
[TBL] [Abstract][Full Text] [Related]
9. Differential Effects of Ontamalimab Versus Vedolizumab on Immune Cell Trafficking in Intestinal Inflammation and Inflammatory Bowel Disease.
Schulze LL; Becker E; Dedden M; Liu LJ; van Passen C; Mohamed-Abdou M; Müller TM; Wiendl M; Ullrich KAM; Atreya I; Leppkes M; Ekici AB; Kirchner P; Stürzl M; Sexton D; Palliser D; Atreya R; Siegmund B; ; Neurath MF; Zundler S
J Crohns Colitis; 2023 Nov; 17(11):1817-1832. PubMed ID: 37208197
[TBL] [Abstract][Full Text] [Related]
10. Vedolizumab Antagonizes MAdCAM-1-Dependent Human Placental Cytotrophoblast Adhesion and Invasion In Vitro.
Blaisdell A; Zhou Y; Kattah MG; Fisher SJ; Mahadevan U
Inflamm Bowel Dis; 2022 Aug; 28(8):1219-1228. PubMed ID: 35349682
[TBL] [Abstract][Full Text] [Related]
11. Inhibiting PGGT1B Disrupts Function of RHOA, Resulting in T-cell Expression of Integrin α4β7 and Development of Colitis in Mice.
López-Posadas R; Fastancz P; Martínez-Sánchez LDC; Panteleev-Ivlev J; Thonn V; Kisseleva T; Becker LS; Schulz-Kuhnt A; Zundler S; Wirtz S; Atreya R; Carlé B; Friedrich O; Schürmann S; Waldner MJ; Neufert C; Brakebusch CH; Bergö MO; Neurath MF; Atreya I
Gastroenterology; 2019 Nov; 157(5):1293-1309. PubMed ID: 31302143
[TBL] [Abstract][Full Text] [Related]
12. Association of Vedolizumab Level, Anti-Drug Antibodies, and α4β7 Occupancy With Response in Patients With Inflammatory Bowel Diseases.
Ungar B; Kopylov U; Yavzori M; Fudim E; Picard O; Lahat A; Coscas D; Waterman M; Haj-Natour O; Orbach-Zingboim N; Mao R; Chen M; Chowers Y; Eliakim R; Ben-Horin S
Clin Gastroenterol Hepatol; 2018 May; 16(5):697-705.e7. PubMed ID: 29223444
[TBL] [Abstract][Full Text] [Related]
13. β7-Integrin exacerbates experimental DSS-induced colitis in mice by directing inflammatory monocytes into the colon.
Schippers A; Muschaweck M; Clahsen T; Tautorat S; Grieb L; Tenbrock K; Gaßler N; Wagner N
Mucosal Immunol; 2016 Mar; 9(2):527-38. PubMed ID: 26349655
[TBL] [Abstract][Full Text] [Related]
14. Review article: nonclinical and clinical pharmacology, pharmacokinetics and pharmacodynamics of etrolizumab, an anti-β7 integrin therapy for inflammatory bowel disease.
Tang MT; Keir ME; Erickson R; Stefanich EG; Fuh FK; Ramirez-Montagut T; McBride JM; Danilenko DM
Aliment Pharmacol Ther; 2018 Jun; 47(11):1440-1452. PubMed ID: 29601644
[TBL] [Abstract][Full Text] [Related]
15. β7 Integrin Inhibition Can Increase Intestinal Inflammation by Impairing Homing of CD25
Sun H; Kuk W; Rivera-Nieves J; Lopez-Ramirez MA; Eckmann L; Ginsberg MH
Cell Mol Gastroenterol Hepatol; 2020; 9(3):369-385. PubMed ID: 31707128
[TBL] [Abstract][Full Text] [Related]
16. Blocking integrin α
Rai RP; Liu Y; Iyer SS; Liu S; Gupta B; Desai C; Kumar P; Smith T; Singhi AD; Nusrat A; Parkos CA; Monga SP; Czaja MJ; Anania FA; Raeman R
J Hepatol; 2020 Nov; 73(5):1013-1022. PubMed ID: 32540177
[TBL] [Abstract][Full Text] [Related]
17. Nasal vaccination of β7 integrin-deficient mice retains elevated IgA immunity.
Maślanka T; Clapp B; Hoffman C; Robison A; Gregorczyk I; Pascual DW
Immunol Cell Biol; 2020 Sep; 98(8):667-681. PubMed ID: 32479679
[TBL] [Abstract][Full Text] [Related]
18. Intestinal mast cell progenitors require CD49dbeta7 (alpha4beta7 integrin) for tissue-specific homing.
Gurish MF; Tao H; Abonia JP; Arya A; Friend DS; Parker CM; Austen KF
J Exp Med; 2001 Nov; 194(9):1243-52. PubMed ID: 11696590
[TBL] [Abstract][Full Text] [Related]
19. Cellular Mechanisms of Etrolizumab Treatment in Inflammatory Bowel Disease.
Lichnog C; Klabunde S; Becker E; Fuh F; Tripal P; Atreya R; Klenske E; Erickson R; Chiu H; Reed C; Chung S; Neufert C; Atreya I; McBride J; Neurath MF; Zundler S
Front Pharmacol; 2019; 10():39. PubMed ID: 30774593
[No Abstract] [Full Text] [Related]
20. The Complexity of alpha E beta 7 Blockade in Inflammatory Bowel Diseases.
Smids C; Horjus Talabur Horje CS; van Wijk F; van Lochem EG
J Crohns Colitis; 2017 Apr; 11(4):500-508. PubMed ID: 27660340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
